Plain-English translation of NCT06779123 on ClinicalTrials.gov ↗ · Source last updated · Translation generated ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a device called transcutaneous auricular vagus nerve stimulation (taVNS) that works by gently stimulating a nerve in your ear to help reduce inflammation in rheumatoid arthritis. The device is small and placed on the ear for 5 minutes, twice daily, and it's designed to activate your body's natural anti-inflammatory system. Researchers want to see if this treatment can help people with rheumatoid arthritis who haven't improved with other standard medications.
Many people with rheumatoid arthritis don't respond well to current treatments, or they experience serious side effects. This trial exists to test a new, non-invasive approach that activates your body's own anti-inflammatory defenses through the vagus nerve, which could offer relief with fewer complications.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll use a small ear-based device for 5 minutes twice a day for 12 weeks. Half of participants will receive actual stimulation from the device, while the other half will use a device that looks the same but delivers no stimulation (to compare results fairly). You'll attend study visits to have your arthritis checked and report how you're feeling, including your pain, tiredness, and how well you're functioning day-to-day.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Sweden